drugset / Trial / NCT05856747
A Study to Compare Two Bioanalytical Assays for Tebipenem
NaSingle-groupOpen-labelTreatment
Summary
The primary purpose of the study is to compare the concentrations of tebipenem (TBP), the active moiety of tebipenem pivoxil hydrobromide (TBP-PI-HBr), as determined by two bioanalytical assays, a whole blood assay and a plasma assay, following a single oral dose of TBP-PI-HBr 600 milligram (mg) tablets in healthy adult participants.
Timeline
- Start
- 2023-05-04
- Primary completion
- 2023-06-01
- Completion
- 2023-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TBP-PI-HBr | Unknown | 600 mg | Oral |
Indications
No indication recorded.